長期投資家のためのIR情報
 バリュートレンド
  1. HOME
  2. バリュートレンド
  3. 【4594】ブライトパス・バイオ

【4594】ブライトパス・バイオ
創薬ベンチャー。がんペプチドワクチンなどを開発。
類似企業：


東証グロース
医薬
＞
新薬
売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)		 対前回 修正率 修正率 営業利益
(百万円)		 対前回 修正率 修正率 経常利益
(百万円)		 対前回 修正率 修正率 当期利益
(百万円)		 対前回 修正率 修正率
2027.03 2026/08/14 Q1予 0 → - - -1,965 → 0.0% 0.0% -1,947 → 0.0% 0.0% -1,949 → 0.0% 0.0%
2027.03 2026/05/14 当初予 0 - - - -1,965 - - - -1,947 - - - -1,949 - - -
2026.03 2026/05/14 実 0 → - - -1,295 ↑ +1.5% -9.6% -1,293 ↑ +1.1% -11.1% -1,304 ↑ +0.5% -11.8%
2026.03 2026/03/13 修正予 0 → - - -1,315 ↓ -11.3% -11.3% -1,308 ↓ -12.4% -12.4% -1,311 ↓ -12.4% -12.4%
2026.03 2026/02/13 Q3予 0 → - - -1,182 → 0.0% 0.0% -1,164 → 0.0% 0.0% -1,166 → 0.0% 0.0%
2026.03 2025/11/14 Q2予 0 → - - -1,182 → 0.0% 0.0% -1,164 → 0.0% 0.0% -1,166 → 0.0% 0.0%
2026.03 2025/08/08 Q1予 0 → - - -1,182 → 0.0% 0.0% -1,164 → 0.0% 0.0% -1,166 → 0.0% 0.0%
2026.03 2025/05/09 当初予 0 - - - -1,182 - - - -1,164 - - - -1,166 - - -
2025.03 2025/05/09 実 1 → 0.0% - -1,160 ↓ -4.1% -25.4% -1,147 ↓ -3.7% -24.0% -1,151 ↓ -3.8% -24.2%
2025.03 2025/03/24 修正予 1 ↑ - - -1,114 ↓ -20.4% -20.4% -1,106 ↓ -19.6% -19.6% -1,109 ↓ -19.6% -19.6%
2025.03 2025/02/14 Q3予 0 → - - -925 → 0.0% 0.0% -925 → 0.0% 0.0% -927 → 0.0% 0.0%
2025.03 2024/11/08 Q2予 0 → - - -925 → 0.0% 0.0% -925 → 0.0% 0.0% -927 → 0.0% 0.0%
2025.03 2024/08/09 Q1予 0 → - - -925 → 0.0% 0.0% -925 → 0.0% 0.0% -927 → 0.0% 0.0%
2025.03 2024/05/10 当初予 0 - - - -925 - - - -925 - - - -927 - - -
2024.03 2024/05/10 実 0 → - - -1,155 ↑ +27.3% +14.6% -1,158 ↑ +27.1% +14.4% -1,168 ↑ +26.6% +13.9%
2024.03 2024/02/09 Q3予 0 → - - -1,588 ↓ -17.4% -17.4% -1,589 ↓ -17.4% -17.4% -1,592 ↓ -17.3% -17.3%
2024.03 2023/11/10 Q2予 - - - - -1,353 → 0.0% 0.0% -1,353 → 0.0% 0.0% -1,357 → 0.0% 0.0%
2024.03 2023/08/10 Q1予 0 → - - -1,353 → 0.0% 0.0% -1,353 → 0.0% 0.0% -1,357 → 0.0% 0.0%
2024.03 2023/05/12 当初予 0 - - - -1,353 - - - -1,353 - - - -1,357 - - -
2023.03 2023/05/12 実 5 → 0.0% 0.0% -1,467 ↑ +10.3% +10.3% -1,473 ↑ +9.9% +9.9% -1,485 ↑ +9.3% +9.3%
2023.03 2023/02/10 Q3予 5 → 0.0% 0.0% -1,635 → 0.0% 0.0% -1,635 → 0.0% 0.0% -1,637 → 0.0% 0.0%
2023.03 2022/11/11 Q2予 5 → 0.0% 0.0% -1,635 → 0.0% 0.0% -1,635 → 0.0% 0.0% -1,637 → 0.0% 0.0%
2023.03 2022/08/12 Q1予 5 → 0.0% 0.0% -1,635 → 0.0% 0.0% -1,635 → 0.0% 0.0% -1,637 → 0.0% 0.0%
2023.03 2022/05/12 当初予 5 - - - -1,635 - - - -1,635 - - - -1,637 - - -
2022.03 2022/05/12 実 15 ↓ -11.8% +650.0% -1,476 ↑ +20.3% +20.3% -1,481 ↑ +20.0% +20.0% -1,484 ↑ +20.0% +20.0%
2022.03 2022/03/30 修正予 17 ↑ +750.0% +750.0% -1,852 → 0.0% 0.0% -1,852 → 0.0% 0.0% -1,854 → 0.0% 0.0%
2022.03 2022/02/10 Q3予 2 → 0.0% 0.0% -1,852 → 0.0% 0.0% -1,852 → 0.0% 0.0% -1,854 → 0.0% 0.0%
2022.03 2021/11/12 Q2予 2 → 0.0% 0.0% -1,852 → 0.0% 0.0% -1,852 → 0.0% 0.0% -1,854 → 0.0% 0.0%
2022.03 2021/08/13 Q1予 2 → 0.0% 0.0% -1,852 → 0.0% 0.0% -1,852 → 0.0% 0.0% -1,854 → 0.0% 0.0%
2022.03 2021/05/13 当初予 2 - - - -1,852 - - - -1,852 - - - -1,854 - - -
2021.03 2021/05/13 実 2 ↓ -33.3% -33.3% -1,732 ↑ +8.6% +8.6% -1,738 ↑ +8.2% +8.2% -1,719 ↑ +9.9% +9.9%
2021.03 2021/02/12 Q3予 3 → 0.0% 0.0% -1,894 → 0.0% 0.0% -1,894 → 0.0% 0.0% -1,907 → 0.0% 0.0%
2021.03 2020/11/13 Q2予 3 → 0.0% 0.0% -1,894 → 0.0% 0.0% -1,894 → 0.0% 0.0% -1,907 → 0.0% 0.0%
2021.03 2020/08/14 Q1予 3 → 0.0% 0.0% -1,894 → 0.0% 0.0% -1,894 → 0.0% 0.0% -1,907 → 0.0% 0.0%
2021.03 2020/05/15 当初予 3 - - - -1,894 - - - -1,894 - - - -1,907 - - -
2020.03 2020/05/15 実 11 → 0.0% +175.0% -1,827 ↑ +24.4% +24.4% -1,823 ↑ +24.6% +24.6% -1,857 ↑ +23.8% +23.8%
2020.03 2020/02/14 Q3予 11 → 0.0% +175.0% -2,417 → 0.0% 0.0% -2,417 → 0.0% 0.0% -2,437 → 0.0% 0.0%
2020.03 2020/01/17 修正予 11 ↑ +175.0% +175.0% -2,417 → 0.0% 0.0% -2,417 → 0.0% 0.0% -2,437 → 0.0% 0.0%
2020.03 2019/11/08 Q2予 4 → 0.0% 0.0% -2,417 → 0.0% 0.0% -2,417 → 0.0% 0.0% -2,437 → 0.0% 0.0%
2020.03 2019/08/09 Q1予 4 → 0.0% 0.0% -2,417 → 0.0% 0.0% -2,417 → 0.0% 0.0% -2,437 → 0.0% 0.0%
2020.03 2019/05/10 当初予 4 - - - -2,417 - - - -2,417 - - - -2,437 - - -
2019.03 2019/05/10 実 155 ↑ +3.3% +3.3% -1,665 ↑ +24.3% +24.3% -1,678 ↑ +23.7% +23.7% -1,884 ↑ +14.4% +14.4%
2019.03 2019/03/15 修正予 150 → 0.0% 0.0% -2,200 → 0.0% 0.0% -2,200 → 0.0% 0.0% -2,200 → 0.0% 0.0%
2019.03 2019/02/14 Q3予 150 → 0.0% 0.0% -2,200 → 0.0% 0.0% -2,200 → 0.0% 0.0% -2,200 → 0.0% 0.0%
2019.03 2018/11/09 Q2予 150 → 0.0% 0.0% -2,200 → 0.0% 0.0% -2,200 → 0.0% 0.0% -2,200 → 0.0% 0.0%
2019.03 2018/08/10 Q1予 150 → 0.0% 0.0% -2,200 - - - -2,200 → 0.0% 0.0% -2,200 → 0.0% 0.0%
2019.03 2018/05/11 当初予 150 - - - - - - - -2,200 - - - -2,200 - - -
2018.03 2018/05/11 実 - - - - - - - - - - - - - - - -
2018.03 2018/02/14 Q3予 280 → 0.0% 0.0% -2,000 → 0.0% 0.0% -2,000 ↑ +90.0% 0.0% -2,000 → 0.0% 0.0%
2018.03 2017/11/10 Q2予 280 → 0.0% 0.0% -2,000 → 0.0% 0.0% -20,000 ↓ -900.0% -900.0% -2,000 → 0.0% 0.0%
2018.03 2017/08/14 Q1予 280 → 0.0% 0.0% -2,000 → 0.0% 0.0% -2,000 → 0.0% 0.0% -2,000 → 0.0% 0.0%
2018.03 2017/05/12 当初予 280 - - - -2,000 - - - -2,000 - - - -2,000 - - -
2017.03 2017/05/12 実 529 ↑ +30.3% +30.3% -1,113 ↑ +14.8% +14.8% -1,116 ↑ +14.5% +14.5% -1,113 ↑ +14.9% +14.9%
2017.03 2017/02/10 修正予 406 → 0.0% 0.0% -1,306 → 0.0% 0.0% -1,306 → 0.0% 0.0% -1,308 → 0.0% 0.0%
2017.03 2016/11/11 Q2予 406 → 0.0% 0.0% -1,306 → 0.0% 0.0% -1,306 → 0.0% 0.0% -1,308 → 0.0% 0.0%
2017.03 2016/08/15 Q1予 406 → 0.0% 0.0% -1,306 → 0.0% 0.0% -1,306 → 0.0% 0.0% -1,308 → 0.0% 0.0%
2017.03 2016/05/13 当初予 406 - - - -1,306 - - - -1,306 - - - -1,308 - - -
2016.03 2016/05/13 実 822 ↓ -1.2% -1.2% -988 ↑ +26.3% +26.3% -992 ↑ +25.3% +25.3% -994 ↑ +25.2% +25.2%
2016.03 2016/02/12 Q3予 832 → 0.0% 0.0% -1,341 → 0.0% 0.0% -1,328 → 0.0% 0.0% -1,329 → 0.0% 0.0%
2016.03 2015/11/13 当初予 832 - - - -1,341 - - - -1,328 - - - -1,329 - - -
シェア ツイート
ページトップへ戻る